Pfizer, BioNTech Challenge GSK Patents Over Vaccine Tech
Pfizer and BioNTech are suing GlaxoSmithKline Biologicals over a range of its patents linked to key processes in the manufacture of COVID-19 vaccines, arguing that the substances were not novel when...To view the full article, register now.
Already a subscriber? Click here to view full article